Tag: Welireg for RCC

Home / Welireg for RCC

Categories

Belzutifan is approved by USFDA for advanced renal cell carcinoma

The Food and Drug Administration granted approval for belzutifan (Welireg, Merck & Co., Inc.) on December 14, 2023, for patients with advanced renal cell carcinoma (RCC) who have previously recei...
welireg-for-rcc

Scan the code